BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29248301)

  • 1. A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification.
    Hung YS; Chang SC; Liu KH; Hung CY; Kuo YC; Tsai CY; Hsu JT; Yeh TS; Chen JS; Chou WC
    Asian J Surg; 2019 Jan; 42(1):85-92. PubMed ID: 29248301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
    Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].
    Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of lymph node ratio for local advanced gastric cancer patients with adjuvant chemoradiotherapy after D2 gastrectomy.
    Hu M; Zhang S; Yang X; Shen Y; Li Z; Zhao Y; Xu F; Jiang D; Wang X; Wang Y
    Medicine (Baltimore); 2018 Nov; 97(44):e13079. PubMed ID: 30383693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
    Hou Y; Wang X; Chen J
    World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.
    Hanyu T; Matsuki A; Kosugi S; Ishikawa T; Nashimoto A; Yabusaki H; Aizawa M; Ichikawa H; Shimada Y; Hirose Y; Wakai T
    Surgery; 2015 Apr; 157(4):716-22. PubMed ID: 25433728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.
    Liu YY; Fang WL; Wang F; Hsu JT; Tsai CY; Liu KH; Yeh CN; Chen TC; Wu RC; Chiu CT; Yeh TS
    Oncologist; 2017 Jan; 22(1):97-106. PubMed ID: 27789777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of No.12 lymph node dissection for advanced gastric cancer].
    You X; Wang Y; Li W; Zhao X; Cheng Z; Xu N; Huang C; Liu G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):283-288. PubMed ID: 28338161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study.
    Li Q; Li G; Palmer JD; Zhang Z
    Am J Clin Oncol; 2017 Aug; 40(4):375-380. PubMed ID: 25503428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymph node ratio as a prognostic factor for gastric cancer.
    Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K
    Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.